RTI SURGICAL, INC. (NASDAQ:RTIX) Files An 8-K Submission of Matters to a Vote of Security Holders

RTI SURGICAL, INC. (NASDAQ:RTIX) Files An 8-K Submission of Matters to a Vote of Security Holders

Story continues below

Item5.07.

Submission of Matters to a Vote of Security
Holders.

On May16, 2017, RTI Surgical, Inc. (the Company) held its 2017
Annual Meeting. All matters submitted to a vote of the Companys
stockholders as described in the proxy statement furnished to
stockholders in connection with the 2017 Annual Meeting, which
was filed with the Securities and Exchange Commission on April3,
2017, were approved.

The number of shares of common stock entitled to vote at the 2017
Annual Meeting was 72,124,058. The number of shares of common
stock present or represented by valid proxy was 59,006,010. At
the 2017 Annual Meeting, the Companys stockholders voted on the
following items:

1. Election of Directors Stockholders voted to elect eight
directors to serve on the Companys board of directors (the Board)
and hold office until the next Annual Meeting of Stockholders or
until their respective successors have been duly elected and
qualified.

The number of votes cast for each of the eight nominees was as
set forth below:

Name

Number of Votes For Number of VotesWithheld

Camille Farhat

58,443,023 562,987

Peter F. Gearen, M.D.

58,170,942 835,068

Thomas A. McEachin

56,015,828 2,990,182

Jonathon M. Singer

57,703,020 1,302,990

Mark D. Stolper

58,568,254 437,756

Paul G. Thomas

58,372,675 633,335

Nicholas J. Valeriani

58,374,926 631,084

Shirley A. Weis

57,851,850 1,154,160

As a result, the following eight individuals were elected, each
to serve on the Board and hold office until the next Annual
Meeting of Stockholders or until their respective successors have
been duly elected and qualified: Camille Farhat, Peter F. Gearen,
M.D., Thomas A. McEachin, Jonathon M. Singer, Mark D. Stolper,
Paul G. Thomas, Nicholas J. Valeriani and Shirley A. Weis.

2. Advisory Vote on Executive Compensation Program (the Say on
Pay Vote)
Stockholders approved (on an advisory basis) the
compensation of the Companys named executive officers, as
disclosed in the proxy statement (the say on pay vote). The vote
totals for the say on pay vote were: 55,653,045 shares for;
549,632 shares against; and 2,803,333 share abstentions.

3. Advisory Vote on the frequency of the Say on Pay Vote
Stockholders conducted an advisory vote on the frequency of the
say on pay vote. The vote totals for the frequency of the say on
pay vote were 47,621,940 shares for holding the say on pay vote
every one year; 41,482 shares for holding the say on pay vote
every two years; 8,548,334 shares for holding the say on pay vote
every three years; and 2,794,254 share abstentions. In light of
the voting results on this advisory proposal, and consistent with
the Boards prior recommendation to the Companys stockholders, the
Board has determined that, until the next required stockholder
vote on the frequency of future stockholder advisory votes on
executive compensation or until the Board determines that such
vote shall be conducted at a different interval, the Company will
hold an advisory vote on executive compensation on an annual
basis.

Banks and brokers were not eligible to vote shares for which they
did not receive instructions from the beneficial owners thereof
on these proposals. The final report of the inspector of election
indicated that there were no broker non-votes on any of these
proposals.


About RTI SURGICAL, INC. (NASDAQ:RTIX)

RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons. The Company distributes its implants and services in approximately 50 states and in over 45 countries across the world.

RTI SURGICAL, INC. (NASDAQ:RTIX) Recent Trading Information

RTI SURGICAL, INC. (NASDAQ:RTIX) closed its last trading session up +0.05 at 4.60 with 402,385 shares trading hands.

An ad to help with our costs